title: Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders.
authors.forename: Francesca
authors.initials: F
authors.lastname: Montanari
authors.forename: Govind
authors.initials: G
authors.lastname: Bhagat
authors.forename: Sean
authors.initials: S
authors.lastname: Clark-Garvey
authors.forename: Venkatraman
authors.initials: V
authors.lastname: Seshan
authors.forename: Jasmine
authors.initials: J
authors.lastname: Zain
authors.forename: Catherine
authors.initials: C
authors.lastname: Diefenbach
authors.forename: Erin
authors.initials: E
authors.lastname: McCormick
authors.forename: Meaghan
authors.initials: M
authors.lastname: Crook
authors.forename: Meghan
authors.initials: M
authors.lastname: Conroy
authors.forename: Owen A
authors.initials: OA
authors.lastname: O'Connor
mesh_terms: D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000473:pathology*; D005260:Female; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000401:mortality*; D015996:Survival Rate; D013601:T-Lymphocytes / Q000473:pathology*; D016896:Treatment Outcome